WEBULL
News
CMND
1.990
+9.94%
0.180
Clearmind Medicine regains compliance with Nasdaq minimum bid price rule
TipRanks · 12/31/2025 14:20
CLEARMIND MEDICINE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
Reuters · 12/31/2025 14:10
Clearmind Medicine Reports Positive Phase I/IIa Results for CMND-100 in Alcohol Use Disorder Trial
Reuters · 12/29/2025 11:04
Weekly Report: what happened at CMND last week (1222-1226)?
Weekly Report · 12/29/2025 09:35
Clearmind Medicine highlights key 2025 achievements
TipRanks · 12/24/2025 14:20
Dr. Adi Zuloff-Shani, CEO Of Clearmind Medicine Says "Looking Ahead To 2026, Clearmind Remains Focused On Advancing Its Pipeline, Generating Additional Clinical Data, And Exploring Strategic Opportunities To Maximize Shareholder Value And Patient Impact"
Benzinga · 12/24/2025 14:16
Clearmind Medicine Advances Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
Reuters · 12/24/2025 14:15
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth
Barchart · 12/24/2025 08:15
Weekly Report: what happened at CMND last week (1215-1219)?
Weekly Report · 12/22/2025 09:35
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial
TipRanks · 12/18/2025 15:35
Clearmind Medicine Completes Enrollment For Second Cohort Of Phase I/IIa AUD Trial Of CMND-100
Benzinga · 12/16/2025 13:46
Clearmind Medicine Completes Second Cohort Enrollment in Phase I/IIa Trial for Alcohol Use Disorder Drug
Reuters · 12/16/2025 13:45
CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF SECOND COHORT ENROLLMENT IN ONGOING FDA-APPROVED PHASE I/IIA TRIAL FOR CMND-100
Reuters · 12/16/2025 13:45
Weekly Report: what happened at CMND last week (1208-1212)?
Weekly Report · 12/15/2025 09:38
Clearmind Medicine Inc trading halted, news pending
TipRanks · 12/13/2025 00:50
Clearmind Medicine announces publication of review of MEAI
TipRanks · 12/12/2025 13:40
Clearmind Medicine Regains Nasdaq Compliance Amid Equity Rule Scrutiny
Reuters · 12/12/2025 11:32
CLEARMIND MEDICINE SUCCESSFULLY REGAINS COMPLIANCE WITH NASDAQ'S MINIMUM STOCKHOLDERS' EQUITY REQUIREMENT
Reuters · 12/12/2025 11:32
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
Barchart · 12/12/2025 07:32
Why Planet Labs Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/11/2025 10:05
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.